Literature DB >> 15893680

Depression in persons with multiple sclerosis.

Dawn M Ehde1, Charles H Bombardier.   

Abstract

This article provides a critical review of what is currently known concerning the nature and scope of depression in persons who have MS. It begins with a discussion of relevant terminology,which is followed by a summary of the research literature concern-ing the prevalence; severity; and risk factors for, and impact of, depression in MS. Assessment issues also are reviewed. Gaps in the literature on the treatment of depression in persons who have MS also are discussed. The article concludes with a discussion of future directions that will improve our understanding of depression, its treatment, and the other side-resilience in the face of a serious neurologic condition.

Entities:  

Mesh:

Year:  2005        PMID: 15893680     DOI: 10.1016/j.pmr.2005.01.010

Source DB:  PubMed          Journal:  Phys Med Rehabil Clin N Am        ISSN: 1047-9651            Impact factor:   1.784


  11 in total

1.  Depression in multiple sclerosis: a longitudinal analysis.

Authors:  Claudia C Beal; Alexa K Stuifbergen; Adama Brown
Journal:  Arch Psychiatr Nurs       Date:  2007-08       Impact factor: 2.218

2.  Relationship between disease-modifying therapy and depression in multiple sclerosis.

Authors:  Stephen S Kirzinger; Jason Jones; Angela Siegwald; Andrew Bryce Crush
Journal:  Int J MS Care       Date:  2013

Review 3.  Co-occurring depression and pain in multiple sclerosis.

Authors:  Kevin N Alschuler; Dawn M Ehde; Mark P Jensen
Journal:  Phys Med Rehabil Clin N Am       Date:  2013-07-23       Impact factor: 1.784

Review 4.  Aerobic capacity in persons with multiple sclerosis: a systematic review and meta-analysis.

Authors:  Martin Langeskov-Christensen; Martin Heine; Gert Kwakkel; Ulrik Dalgas
Journal:  Sports Med       Date:  2015-06       Impact factor: 11.136

5.  Phenelzine (monoamine oxidase inhibitor) increases production of nitric oxide and proinflammatory cytokines via the NF-κB pathway in lipopolysaccharide-activated microglia cells.

Authors:  Hwan-Suck Chung; Hyunseong Kim; Hyunsu Bae
Journal:  Neurochem Res       Date:  2012-07-05       Impact factor: 3.996

6.  Beyond depression: Predictors of self-reported cognitive function in adults living with MS.

Authors:  Meghan Beier; Dagmar Amtmann; Dawn M Ehde
Journal:  Rehabil Psychol       Date:  2015-07-20

7.  Relationship between psychosocial factors and onset of multiple sclerosis.

Authors:  X J Liu; H X Ye; W P Li; R Dai; D Chen; M Jin
Journal:  Eur Neurol       Date:  2009-07-01       Impact factor: 1.710

8.  Cross-Sectional Examination of the Associations Between Symptoms, Community Integration, and Mental Health in Multiple Sclerosis.

Authors:  Anna L Kratz; Dawn M Ehde; Marisol A Hanley; Mark P Jensen; Travis L Osborne; George H Kraft
Journal:  Arch Phys Med Rehabil       Date:  2015-10-31       Impact factor: 3.966

Review 9.  Neuropsychiatric manifestations of depression in multiple sclerosis: neuroinflammatory, neuroendocrine, and neurotrophic mechanisms in the pathogenesis of immune-mediated depression.

Authors:  Michele L Pucak; Katherine A L Carroll; Douglas A Kerr; Adam I Kaplin
Journal:  Dialogues Clin Neurosci       Date:  2007       Impact factor: 5.986

10.  Internet-based self-help treatment for depression in multiple sclerosis: study protocol of a randomized controlled trial.

Authors:  Rosa E Boeschoten; Joost Dekker; Bernard M J Uitdehaag; Chris H Polman; Emma H Collette; Pim Cuijpers; Aartjan T F Beekman; Patricia van Oppen
Journal:  BMC Psychiatry       Date:  2012-09-11       Impact factor: 3.630

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.